STAT podcast highlights investor buzz around hair loss drugs, AI in trials, and Servier's M&A ambitions
The latest episode of STAT’s “The Readout LOUD” podcast explored why investors are increasingly focused on treatments for hair loss, noting recent trial data that has generated notable market interest.
The hosts also examined the growing role of artificial intelligence in streamlining clinical trial operations, discussing potential benefits and challenges as the technology matures.
In addition, the conversation turned to Servier’s strategic outlook, with the nonprofit pharma company outlining its ambitions for mergers and acquisitions, and featuring insights from Veradermics CEO Reid Waldman.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Hair-raising trial results, and Servier’s M&A wishlist”
read at STAT ↗
comments(0)
5-min edit window · permanent after that